SurgePays, Inc.

SURG · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Valuation
PEG Ratio0.00-0.001.220.02
FCF Yield-64.14%10.88%0.12%-173.31%
EV / EBITDA-0.654.1234.41-2.01
Quality
ROIC-210.45%55.74%4.79%-53.35%
Gross Margin-23.53%25.99%11.08%12.08%
Cash Conversion Ratio0.460.50-1.431.13
Growth
Revenue 3-Year CAGR-20.58%39.00%30.73%3,709,797.75%
Free Cash Flow Growth-318.16%10,467.16%100.62%-254.05%
Safety
Net Debt / EBITDA0.17-0.460.45-0.27
Interest Coverage-75.3931.650.32-0.80
Efficiency
Inventory Turnover42.2211.229.6610.30
Cash Conversion Cycle7.5634.7645.96-1.80